0000899243-20-018288.txt : 20200702 0000899243-20-018288.hdr.sgml : 20200702 20200702162808 ACCESSION NUMBER: 0000899243-20-018288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turtle Cameron CENTRAL INDEX KEY: 0001758363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 201009776 MAIL ADDRESS: STREET 1: C/O EIDOS THERAPEUTICS, INC. STREET 2: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-30 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001758363 Turtle Cameron C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 See Remarks Common Stock 2020-06-30 4 M 0 6000 0.16 A 15823 D Common Stock 2020-06-30 4 M 0 4000 0.34 A 19823 D Common Stock 2020-06-30 4 S 0 9700 32.6465 D 10123 D Common Stock 2020-06-30 4 S 0 300 33.1733 D 9823 D Stock Option (Right to Buy) 0.16 2020-06-30 4 M 0 6000 0.00 D 2020-05-19 2029-05-23 Common Stock 6000 68042 D Stock Option (Right to Buy) 0.34 2020-06-30 4 M 0 4000 0.00 D 2020-05-19 2029-07-14 Common Stock 4000 45766 D Represents the weighted average sale price of the shares sold from $32.12 to $33.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2. Represents the weighted average sale price of the shares sold from $33.13 to $33.23 per share. Senior Vice President, Portfolio Management and Corporate Development /s/ Tara Condon, Attorney-in-Fact 2020-07-02